バイオサージェリー市場：製品タイプ別（抗接着剤、骨移植片代替物、止血剤および外科用シーラント、メッシュ）、用途別（心臓血管および胸部外科、神経および脊椎外科、整形外科、一般外科）、供給元別（生物製剤、合成製剤）。世界の機会分析および産業予測、2020-2030年

Biosurgery Market By Product Type (Anti Adhesive Agents, Bone Graft Substitutes, Hemostatic And Surgical Sealant, Mesh), By Application (Cardiovascular And Thoracic Surgery, Neuro And Spine Surgery, Orthopedic Surgery, General Surgery), By Source (Biologics Products, Synthetic Products): Global Opportunity Analysis and Industry Forecast, 2020-2030

バイオサージェリーの世界市場は、2020年に11,425.5百万ドルと評価され、2021年から2030年までCAGR9.1%を記録し、2030年までに27,324.8百万ドルに達すると予測されています。バイオサージェリー製品は、組織修... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年5月31日	US$5,939 シングルユーザーライセンスライセンス・価格情報注文方法はこちら	180	英語

サマリー

バイオサージェリーの世界市場は、2020年に11,425.5百万ドルと評価され、2021年から2030年までCAGR9.1%を記録し、2030年までに27,324.8百万ドルに達すると予測されています。
バイオサージェリー製品は、組織修復や外科的切開の密封に役立つ合成、半合成、または天然材料で構成されています。バイオサージェリー製品は、さまざまな手術で使用され、術中および術後の合併症を最小限に抑えます。また、バイオサージェリー製品は、組織密封止血を促進するのに役立ちます。さらに、バイオサージェリー製品は、オルソバイオロジックの硬組織再生に使用されています。抗接着剤、止血剤、外科用シーリング剤、骨移植片代替物、軟組織管理などの様々な合成および生物学的製品は、過剰な血液損失の防止や接着または創傷/組織シーリングを行うために手術に利用されています。
バイオサージェリーの世界市場の成長は、慢性疾患の有病率の増加、外傷、医療機器セクターの開発のための政府および民間組織のイニシアティブの上昇、外科手術の数の急増、バイオサージェリー製品の需要の上昇によって大きく左右されます。
さらに、老年人口数の増加は、市場の成長を促進します。これは、老年人口が慢性疾患に非常に脆弱であるという事実に起因しており、様々な外科手術の必要性を高め、バイオサージェリー製品の需要を急増させる。この要因は、世界のバイオサージェリー市場の成長に向けて著しく貢献すると予想されます。
また、スポーツ関連の怪我や手術の増加、座りがちなライフスタイルの増加、バイオサージェリーのためのいくつかの承認の上昇は、世界のバイオサージェリー市場の成長を促進する。
さらに、ヘルスケア産業におけるR&D活動の増加や出血管理システムの上昇は、市場拡大のための有利な機会を提供すると予想されます。

しかし、バイオサージェリー製品のコスト高と政府の厳しい規制が市場成長を妨げています。逆に、バイオサージェリー製品の使用に関する医師や研究者の意識の高まりは、バイオサージェリー市場の成長を増大させます。これは、さらに多くの主要なプレーヤーが新興国市場に参入することを奨励しているため、バイオサージェリー市場の拡大のための有利な機会を提供しています。

バイオサージェリー市場は、製品タイプ、アプリケーション、ソース、地域に基づいてセグメント化されています。製品タイプにより、市場は接着防止剤、止血剤および外科用シーラント、骨移植片代替物、メッシュ（軟組織管理）に分けられます。用途別では、心臓血管・胸部外科、神経・脊椎外科、整形外科、一般外科に分類されます。供給元ベースでは、市場は生物学的製剤と合成製剤に区分けされています。地域別では、北米、欧州、アジア太平洋地域、LAMEAに分析されています。

世界のバイオサージェリー市場で活動する主要企業には、Aroa Biosurgery Limited、B. Braun Melsungen AG、Baxter International Inc、BD (Becton, Dickinson and Company) 、Hemostasis LLC、Integra LifeSciences Holdings Corp、Johnson and Johnson、Medtronic PLC、Sanofi S.A. 、Tissue Regenix Groups、Technisches Inc.があります。

ページTOPに戻る

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: BIOSURGERY MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Anti Adhesive Agents
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Bone Graft Substitutes
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Hemostatic And Surgical Sealant
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Mesh
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
CHAPTER 5: BIOSURGERY MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Cardiovascular And Thoracic Surgery
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Neuro And Spine Surgery
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Orthopedic Surgery
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 General Surgery
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: BIOSURGERY MARKET, BY SOURCE
6.1 Overview
6.1.1 Market size and forecast
6.2 Biologics Products
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Synthetic Products
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: BIOSURGERY MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product Type
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by Source
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product Type
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by Source
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product Type
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by Source
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product Type
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by Source
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by Source
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product Type
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by Source
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product Type
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by Source
7.3.5.3 United Kingdom
7.3.5.3.1 Market size and forecast, by Product Type
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by Source
7.3.5.4 Rest of Europe
7.3.5.4.1 Market size and forecast, by Product Type
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by Source
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by Source
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Product Type
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by Source
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Product Type
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by Source
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Product Type
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by Source
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Product Type
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by Source
7.4.5.5 Rest of Asia-Pacific
7.4.5.5.1 Market size and forecast, by Product Type
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by Source
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by Source
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product Type
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by Source
7.5.5.2 Turkey
7.5.5.2.1 Market size and forecast, by Product Type
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by Source
7.5.5.3 Saudi Arabia
7.5.5.3.1 Market size and forecast, by Product Type
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by Source
7.5.5.4 South Africa
7.5.5.4.1 Market size and forecast, by Product Type
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by Source
7.5.5.5 Rest of LAMEA
7.5.5.5.1 Market size and forecast, by Product Type
7.5.5.5.2 Market size and forecast, by Application
7.5.5.5.3 Market size and forecast, by Source
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 aroa biosurgery limited
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Baxter International Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 B. BRAUN MELSUNGEN AG
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Becton, Dickinson and Company
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 HEMOSTASIS LLC
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 INTEGRA LIFE SCIENCES HOLDINGS CORP
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 JOHNSON and JOHNSON SERVICES, INC.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Medtronic, Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 SANOFI S A
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 TISSUE REGENIX GROUP
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL BIOSURGERY MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 2. BIOSURGERY MARKET REVENUE, FOR ANTI ADHESIVE AGENTS, BY REGION , 2020-2030,($MILLION)
TABLE 3. BIOSURGERY MARKET ANTI ADHESIVE AGENTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. BIOSURGERY MARKET REVENUE, FOR BONE GRAFT SUBSTITUTES, BY REGION , 2020-2030,($MILLION)
TABLE 5. BIOSURGERY MARKET BONE GRAFT SUBSTITUTES BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. BIOSURGERY MARKET REVENUE, FOR HEMOSTATIC AND SURGICAL SEALANT, BY REGION , 2020-2030,($MILLION)
TABLE 7. BIOSURGERY MARKET HEMOSTATIC AND SURGICAL SEALANT BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. BIOSURGERY MARKET REVENUE, FOR MESH, BY REGION , 2020-2030,($MILLION)
TABLE 9. BIOSURGERY MARKET MESH BY COUNTRY, 2020-2030,($MILLION)
TABLE 10. GLOBAL BIOSURGERY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 11. BIOSURGERY MARKET REVENUE, FOR CARDIOVASCULAR AND THORACIC SURGERY, BY REGION , 2020-2030,($MILLION)
TABLE 12. BIOSURGERY MARKET CARDIOVASCULAR AND THORACIC SURGERY BY COUNTRY, 2020-2030,($MILLION)
TABLE 13. BIOSURGERY MARKET REVENUE, FOR NEURO AND SPINE SURGERY, BY REGION , 2020-2030,($MILLION)
TABLE 14. BIOSURGERY MARKET NEURO AND SPINE SURGERY BY COUNTRY, 2020-2030,($MILLION)
TABLE 15. BIOSURGERY MARKET REVENUE, FOR ORTHOPEDIC SURGERY, BY REGION , 2020-2030,($MILLION)
TABLE 16. BIOSURGERY MARKET ORTHOPEDIC SURGERY BY COUNTRY, 2020-2030,($MILLION)
TABLE 17. BIOSURGERY MARKET REVENUE, FOR GENERAL SURGERY, BY REGION , 2020-2030,($MILLION)
TABLE 18. BIOSURGERY MARKET GENERAL SURGERY BY COUNTRY, 2020-2030,($MILLION)
TABLE 19. GLOBAL BIOSURGERY MARKET, BY SOURCE, 2020-2030,($MILLION)
TABLE 20. BIOSURGERY MARKET REVENUE, FOR BIOLOGICS PRODUCTS, BY REGION , 2020-2030,($MILLION)
TABLE 21. BIOSURGERY MARKET BIOLOGICS PRODUCTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 22. BIOSURGERY MARKET REVENUE, FOR SYNTHETIC PRODUCTS, BY REGION , 2020-2030,($MILLION)
TABLE 23. BIOSURGERY MARKET SYNTHETIC PRODUCTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 24. BIOSURGERY MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 25. NORTH AMERICA BIOSURGERY MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 26. NORTH AMERICA BIOSURGERY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 27. NORTH AMERICA BIOSURGERY MARKET, BY SOURCE, 2020-2030,($MILLION)
TABLE 28. NORTH AMERICA BIOSURGERY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 29. U.S. BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 30. U.S. BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 31. U.S. BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 32. CANADA BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 33. CANADA BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 34. CANADA BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 35. MEXICO BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 36. MEXICO BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 37. MEXICO BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 38. EUROPE BIOSURGERY MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 39. EUROPE BIOSURGERY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 40. EUROPE BIOSURGERY MARKET, BY SOURCE, 2020-2030,($MILLION)
TABLE 41. EUROPE BIOSURGERY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 42. GERMANY BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 43. GERMANY BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 44. GERMANY BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 45. FRANCE BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 46. FRANCE BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 47. FRANCE BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 48. UNITED KINGDOM BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 49. UNITED KINGDOM BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 50. UNITED KINGDOM BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 51. REST OF EUROPE BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 52. REST OF EUROPE BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 53. REST OF EUROPE BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 54. ASIA-PACIFIC BIOSURGERY MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 55. ASIA-PACIFIC BIOSURGERY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 56. ASIA-PACIFIC BIOSURGERY MARKET, BY SOURCE, 2020-2030,($MILLION)
TABLE 57. ASIA-PACIFIC BIOSURGERY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 58. CHINA BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 59. CHINA BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 60. CHINA BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 61. JAPAN BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 62. JAPAN BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 63. JAPAN BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 64. AUSTRALIA BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 65. AUSTRALIA BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 66. AUSTRALIA BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 67. INDIA BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 68. INDIA BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 69. INDIA BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 70. REST OF ASIA-PACIFIC BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 71. REST OF ASIA-PACIFIC BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 72. REST OF ASIA-PACIFIC BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 73. LAMEA BIOSURGERY MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
TABLE 74. LAMEA BIOSURGERY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 75. LAMEA BIOSURGERY MARKET, BY SOURCE, 2020-2030,($MILLION)
TABLE 76. LAMEA BIOSURGERY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 77. BRAZIL BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 78. BRAZIL BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 79. BRAZIL BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 80. TURKEY BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 81. TURKEY BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 82. TURKEY BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 83. SAUDI ARABIA BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 84. SAUDI ARABIA BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 85. SAUDI ARABIA BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 86. SOUTH AFRICA BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 87. SOUTH AFRICA BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 88. SOUTH AFRICA BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 89. REST OF LAMEA BIOSURGERY MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
TABLE 90. REST OF LAMEA BIOSURGERY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 91. REST OF LAMEA BIOSURGERY MARKET BY SOURCE 2020-2030,($MILLION)
TABLE 92.AROA BIOSURGERY LIMITED: COMPANY SNAPSHOT
TABLE 93.AROA BIOSURGERY LIMITED: OPERATING SEGMENTS
TABLE 94.AROA BIOSURGERY LIMITED: PRODUCT PORTFOLIO
TABLE 95.AROA BIOSURGERY LIMITED: NET SALES,
TABLE 96.AROA BIOSURGERY LIMITED: KEY STRATERGIES
TABLE 97.BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 98.BAXTER INTERNATIONAL INC.: OPERATING SEGMENTS
TABLE 99.BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 100.BAXTER INTERNATIONAL INC.: NET SALES,
TABLE 101.BAXTER INTERNATIONAL INC.: KEY STRATERGIES
TABLE 102.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 103.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 104.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 105.B. BRAUN MELSUNGEN AG: NET SALES,
TABLE 106.B. BRAUN MELSUNGEN AG: KEY STRATERGIES
TABLE 107.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 108.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 109.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 110.BECTON, DICKINSON AND COMPANY: NET SALES,
TABLE 111.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 112.HEMOSTASIS LLC: COMPANY SNAPSHOT
TABLE 113.HEMOSTASIS LLC: OPERATING SEGMENTS
TABLE 114.HEMOSTASIS LLC: PRODUCT PORTFOLIO
TABLE 115.HEMOSTASIS LLC: NET SALES,
TABLE 116.HEMOSTASIS LLC: KEY STRATERGIES
TABLE 117.INTEGRA LIFE SCIENCES HOLDINGS CORP: COMPANY SNAPSHOT
TABLE 118.INTEGRA LIFE SCIENCES HOLDINGS CORP: OPERATING SEGMENTS
TABLE 119.INTEGRA LIFE SCIENCES HOLDINGS CORP: PRODUCT PORTFOLIO
TABLE 120.INTEGRA LIFE SCIENCES HOLDINGS CORP: NET SALES,
TABLE 121.INTEGRA LIFE SCIENCES HOLDINGS CORP: KEY STRATERGIES
TABLE 122.JOHNSON AND JOHNSON SERVICES, INC.: COMPANY SNAPSHOT
TABLE 123.JOHNSON AND JOHNSON SERVICES, INC.: OPERATING SEGMENTS
TABLE 124.JOHNSON AND JOHNSON SERVICES, INC.: PRODUCT PORTFOLIO
TABLE 125.JOHNSON AND JOHNSON SERVICES, INC.: NET SALES,
TABLE 126.JOHNSON AND JOHNSON SERVICES, INC.: KEY STRATERGIES
TABLE 127.MEDTRONIC, INC.: COMPANY SNAPSHOT
TABLE 128.MEDTRONIC, INC.: OPERATING SEGMENTS
TABLE 129.MEDTRONIC, INC.: PRODUCT PORTFOLIO
TABLE 130.MEDTRONIC, INC.: NET SALES,
TABLE 131.MEDTRONIC, INC.: KEY STRATERGIES
TABLE 132.SANOFI S A: COMPANY SNAPSHOT
TABLE 133.SANOFI S A: OPERATING SEGMENTS
TABLE 134.SANOFI S A: PRODUCT PORTFOLIO
TABLE 135.SANOFI S A: NET SALES,
TABLE 136.SANOFI S A: KEY STRATERGIES
TABLE 137.TISSUE REGENIX GROUP: COMPANY SNAPSHOT
TABLE 138.TISSUE REGENIX GROUP: OPERATING SEGMENTS
TABLE 139.TISSUE REGENIX GROUP: PRODUCT PORTFOLIO
TABLE 140.TISSUE REGENIX GROUP: NET SALES,
TABLE 141.TISSUE REGENIX GROUP: KEY STRATERGIES

LIST OF FIGURES
FIGURE 1.BIOSURGERY MARKET SEGMENTATION
FIGURE 2.BIOSURGERY MARKET,2020-2030
FIGURE 3.BIOSURGERY MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.BIOSURGERY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.BIOSURGERY MARKET,BY PRODUCT TYPE,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF ANTI ADHESIVE AGENTS BIOSURGERY MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF BONE GRAFT SUBSTITUTES BIOSURGERY MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF HEMOSTATIC AND SURGICAL SEALANT BIOSURGERY MARKET,2020-2030(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF MESH BIOSURGERY MARKET,2020-2030(%)
FIGURE 16.BIOSURGERY MARKET,BY APPLICATION,2020(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR AND THORACIC SURGERY BIOSURGERY MARKET,2020-2030(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF NEURO AND SPINE SURGERY BIOSURGERY MARKET,2020-2030(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC SURGERY BIOSURGERY MARKET,2020-2030(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF GENERAL SURGERY BIOSURGERY MARKET,2020-2030(%)
FIGURE 21.BIOSURGERY MARKET,BY SOURCE,2020(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF BIOLOGICS PRODUCTS BIOSURGERY MARKET,2020-2030(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF SYNTHETIC PRODUCTS BIOSURGERY MARKET,2020-2030(%)
FIGURE 24.BIOSURGERY MARKET BY REGION,2020
FIGURE 25.U.S. BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 26.CANADA BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 27.MEXICO BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 28.GERMANY BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 29.FRANCE BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 30.UNITED KINGDOM BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 31.REST OF EUROPE BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 32.CHINA BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 33.JAPAN BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 34.AUSTRALIA BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 35.INDIA BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 36.REST OF ASIA-PACIFIC BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 37.BRAZIL BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 38.TURKEY BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 39.SAUDI ARABIA BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 40.SOUTH AFRICA BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 41.REST OF LAMEA BIOSURGERY MARKET,2020-2030($MILLION)
FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 46.COMPETITIVE DASHBOARD
FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 48.AROA BIOSURGERY LIMITED.: NET SALES ,($MILLION)
FIGURE 49.BAXTER INTERNATIONAL INC..: NET SALES ,($MILLION)
FIGURE 50.B. BRAUN MELSUNGEN AG.: NET SALES ,($MILLION)
FIGURE 51.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)
FIGURE 52.HEMOSTASIS LLC.: NET SALES ,($MILLION)
FIGURE 53.INTEGRA LIFE SCIENCES HOLDINGS CORP.: NET SALES ,($MILLION)
FIGURE 54.JOHNSON AND JOHNSON SERVICES, INC..: NET SALES ,($MILLION)
FIGURE 55.MEDTRONIC, INC..: NET SALES ,($MILLION)
FIGURE 56.SANOFI S A.: NET SALES ,($MILLION)
FIGURE 57.TISSUE REGENIX GROUP.: NET SALES ,($MILLION)

ページTOPに戻る

Table of Contents

Summary

The global Biosurgery market was valued at $11,425.5 million in 2020, and is projected to reach $27,324.8 million by 2030, registering a CAGR of 9.1% from 2021 to 2030.
Biosurgery products consist of synthetic, semisynthetic or natural material that help in tissue repair and seal surgical incision. Biosurgery products are used in various surgeries to minimize the intra and post-operative complications. Biosurgery products also help facilitate tissue sealing hemostasis. Moreover, biosurgery products are used in hard tissue regeneration in ortho-biologics. Various synthetic and biologic products, such as anti-adhesive agents, hemostatic agents, surgical sealing agents, bone graft substitutes, and soft tissue management are utilized in surgeries for prevention of excessive blood loss or providing adhesion or wound/tissue sealing.
The growth of the global biosurgery market is majorly driven by increase in prevalence of chronic disease, trauma, rise in government and private organizations initiatives for development of the medical devices sector, surge in number of surgical procedures, and rise in demand for biosurgery products.
Furthermore, rise in number of geriatric population drives the growth of the market. This is attributed to the fact that geriatric population is highly vulnerable to chronic diseases, which boosts the need for various surgical procedure and upsurge the demand for biosurgery products. This factor is expected to notably contribute toward the growth of the global biosurgery market.
In addition, increase in sports-related injuries and surgeries, increase in sedentary lifestyle, and rise in several approvals for biosurgery, drive the growth of the global biosurgery market.
In addition, increase in R&D activities in the healthcare industry and rise in blood loss management systems are anticipated to provide lucrative opportunities for the market expansion.

However, high cost of biosurgery products and stringent government regulations hinder the market growth. On the contrary, increase in awareness among physicians and researchers about the use of biosurgery products augments the growth of the biosurgery market. This has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities for the expansion of the biosurgery market.

The biosurgery market is segmented on the basis of product type, application, source, and region. Depending on the product type, the market is divided into anti-adhesive agents, hemostatic agents and surgical sealants, bone graft substitutes, and mesh (soft tissue management). On the basis of application, the market is segmented into cardiovascular and thoracic, neuro and spine surgery, orthopedic surgery, and general surgery. On the basis of source, the market is segmented into biologics products, and synthetic products. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global biosurgery market are Aroa Biosurgery Limited, B. Braun Melsungen AG, Baxter International Inc., BD (Becton, Dickinson and Company), Hemostasis LLC, Integra LifeSciences Holdings Corp., Johnson and Johnson, Medtronic PLC, Sanofi S.A., Tissue Regenix Groups.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（中枢神経系作用薬）の最新刊レポート

Allied Market Research社の中枢神経系作用薬分野での最新刊レポート

本レポートと同じKEY WORD（biosurgery）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（中枢神経系作用薬）の最新刊レポート

Allied Market Research社の中枢神経系作用薬分野での最新刊レポート

本レポートと同じKEY WORD（biosurgery）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?